Abbott (ABT) Reports Favorable Findings From RELIEF Study

This article was originally published on Nasdaq

Abbott Laboratories ABT recently presented new data from the Real World Evidence of FreeStyle Libre (RELIEF) study at the 58th Annual European Association for the Study of Diabetes (EASD) meeting. According to the latest findings, Type 2 diabetes patients receiving once-d

Responses